CNNC Company Profile and Key Details

Average 10-day trading volume of 820.00 shares is below the 3-month average of 6.33 thousand, indicating normal recent market interest.

Dividend and splits history remains an important factor for investors monitoring long-term returns.

The stock is currently mid-range between its 52-week high and low $0.00 and $0.04. With a market capitalization of about $72.41 thousand, Cannonau Corp. is classified as a micro-cap and shows higher-than-market volatility (beta ~2.09). Key stats such as the average daily volume over the past year has been around 2.45 thousand shares, in line with its 52-week average. Headquartered in Skaneateles, NY, Cannonau Corp. operates in the Healthcare sector and the Drug Manufacturers - Specialty & Generic industry. Led by CEO Markwin Maring, the company employs approximately 4 people and listed since March 12, 2010. Cannonau Corp. specializes in the development and marketing of products based on cannabidiol.

Cannonau Corp. trades at a P/E ratio of 0.0, slightly below the S&P 500 average, with a price-to-sales ratio of 0.0 The P/FCF stands at -461.23, also below market averages.

Our AI price prediction model suggests that Cannonau Corp. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term.

Valuation shows Cannonau Corp. trading at a premium to the broader market with a P/E of 0.0.